Catubig, Daylyn .

HRN: 14-79-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2026
CEFUROXIME 750MG (VIAL)
04/15/2026
04/22/2026
IVTT
750mg
Q8h
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: